Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accommodate, afoul, AGC, airway, alert, awake, Axsome, bankruptcy, benchmark, calcium, Carr, Cavion, chain, checked, chemotherapeutic, China, clock, compendia, conference, CPAP, diffuse, discover, embedded, erratic, Finbar, GP, Iannone, ineligible, inhibitor, Inline, JZP, Larkin, Latin, LBL, London, lung, lurbinectedin, lymphoma, Malta, Mar, Mike, modulator, movement, mutant, Neena, neuroscience, oversee, Patil, Patricia, Pearce, pharm, PharmaMar, phone, presidential, RAF, RAS, reboxetine, Redx, Robert, run, Samantha, SCLC, Sunosi, today, topotecan, tremor, unfit, unplanned, vehicle, XBRL
Removed:
accuracy, Activase, activator, add, adhere, adjusting, affiliate, aimed, Aliz, alteplase, amend, anthracycline, antithrombin, arise, backup, banking, began, begin, beneficially, bifurcated, bioequivalence, borrowed, breakdown, broadened, broker, budgeted, call, cessation, clarification, Clarifying, clear, clearance, climate, CMC, collaborate, compare, complement, compound, comprising, connected, constructed, construction, consulted, controlling, Conversely, converted, cooperating, counterfeit, crisantaspase, custom, damaged, depict, Depositary, designing, desire, dispersion, disposing, dissemination, distract, Double, draft, DWT, earthquake, EEA, enact, enforcing, existence, expend, expose, facilitate, factual, fashion, feedback, fire, flood, flux, Genentech, govern, ground, half, heparin, HHS, Hooper, House, hypnogogic, hypocretin, hypothesized, Iain, illegally, incomplete, indirect, initiated, insomnia, intense, intrathecal, jeopardized, karen, lag, land, landlord, lien, literature, MAA, McGill, membership, migration, mixed, nationally, negotiation, occurred, optimized, orexin, Parkinson, perception, permanent, plasminogen, poverty, predictive, preparing, President, principle, privately, problematic, properly, proposing, prosecuting, psychiatry, publish, punished, ratified, rating, rational, redeemable, redesign, relying, remained, repeat, resolution, resolving, role, satisfactory, Sawochka, scientific, sector, short, somnolence, spend, stabilize, stagger, stronger, strongest, suffered, summarized, supermajority, surrendered, surveillance, suspected, sustain, Suzanne, switch, telecommunication, tendered, terrorism, Thrombate, tissue, traditional, transferee, transform, Trump, unannounced, uniform, universal, unnecessary, unpredictable, unreliable, validation, validly, valuable, vice, vote, waive, wilson, withdrawn, workforce, ziconotide
Filing tables
Filing exhibits
- 10-K Annual report
- 4.6 Description of Share Capital
- 10.10 Contract Manufacturing Agreement
- 10.22 Compromise Agreement
- 10.27 Employment Contract
- 10.28 Employment Contract
- 10.28 Equity Award Letter
- 10.34 Cash Bonus Plan U.s
- 10.34 Cash Bonus Plan (Ireland and Other)
- 21.1 List of Subsidiaries
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Peo and Interim Pfo Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certification of Peo and Interim Pfo Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated JAZZ transcripts
JAZZ similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Jazz Pharmaceuticals plc
We consent to the incorporation by reference in the registration statements (No. 333‑229889, No. 333-224757, No. 333-216338, No. 333-209767, No. 333-202269, No. 333-194131, No. 333-186886 and No. 333-179075) on Form S-8 of Jazz Pharmaceuticals plc of our reports dated February 25, 2020, with respect to the consolidated balance sheets of Jazz Pharmaceuticals plc as of December 31, 2019 and 2018, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes and financial statement schedule at Item 15(a)2, and the effectiveness of internal control over financial reporting as of December 31, 2019, which reports appear in the December 31, 2019 annual report on Form 10‑K of Jazz Pharmaceuticals plc.
/s/ KPMG
KPMG
Dublin, Ireland
February 25, 2020